Index of reports
> Cases with Fall (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nipent (Pentostatin) where reactions include fall. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nipent side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-17
Patient: 70 year old male, weighing 66.3 kg (145.9 pounds)
Reactions: Productive Cough, Rales, Pericardial Effusion, Cardiomegaly, Oedema Peripheral, Pneumothorax, Cardiac Failure Congestive, Bronchopulmonary Aspergillosis, Pulmonary Necrosis, Cytomegalovirus Test Positive, Anaemia, Hypotension, Pancytopenia, Rhonchi, Dehydration, non-Small Cell Lung Cancer, Atelectasis, Confusional State, Nuchal Rigidity, Fall, Fatigue, Pleural Effusion, Musculoskeletal Stiffness, Sinusitis, Thrombocytopenia, Lethargy, Candidiasis, Decreased Appetite, Dyspnoea, Lung Neoplasm, Jugular Vein Distension, Cerebral Atrophy, Ascites, Hypophagia, Bradycardia, Bronchitis, Gait Disturbance, Asthenia, Blood Pressure Fluctuation, Face Injury
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alemtuzumab
Dosage: 60 mg, not reported
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-02
Cyclophosphamide
Dosage: 1212mg, not reported
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Nipent
Dosage: 8 mg, not reported
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Rituximab
Dosage: 758 mg, not reported
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Possible Nipent side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-19
Patient: 70 year old male, weighing 66.3 kg (145.9 pounds)
Reactions: Lung Infection, Pericardial Effusion, Cardiomegaly, Pneumothorax, Cardiac Failure Congestive, Cytomegalovirus Test Positive, Hypotension, Pancytopenia, Fungal Infection, Dehydration, Depressed Level of Consciousness, non-Small Cell Lung Cancer, Mobility Decreased, Confusional State, Atelectasis, Effusion, Nuchal Rigidity, Fall, Musculoskeletal Stiffness, Abdominal Distension, Sinusitis, Candidiasis, Jugular Vein Distension, Lung Neoplasm, Cerebral Atrophy, Ascites, Disease Recurrence, Aspergillosis, Bronchitis, Bradycardia, Blood Pressure Fluctuation, Face Injury
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
(Alemtuzumab)
Dosage: 60 mg,
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-02
(Rituximab)
Dosage: 758 mg
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Cyclophosphamide
Dosage: 1212 mg,
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Nipent
Dosage: 8 mg
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Possible Nipent side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-12
Patient: 70 year old male, weighing 61.0 kg (134.3 pounds)
Reactions: Confusional State, Atelectasis, Lung Infection, Nuchal Rigidity, Fall, Cardiomegaly, Pericardial Effusion, Fatigue, Oedema Peripheral, Musculoskeletal Stiffness, Pleural Effusion, Thrombocytopenia, Candidiasis, Lethargy, Cardiac Failure Congestive, Dyspnoea, Cytomegalovirus Test Positive, Anaemia, Cerebral Atrophy, Pancytopenia, Ascites, Fungal Infection, Dehydration, non-Small Cell Lung Cancer, Bronchitis, Face Injury, Mobility Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
(Alemtuzumab)
Dosage: 60 mg,
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-02
(Rituximab)
Dosage: 758 mg
Indication: Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Cyclophosphamide
Dosage: 1212 mg,
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Nipent
Dosage: 8 mg,
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Possible Nipent side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-27
Patient: 70 year old male, weighing 67.9 kg (149.4 pounds)
Reactions: Dyspnoea, Anaemia, Muscular Weakness, Hypoaesthesia, Fall, Paraesthesia, Fatigue, Dehydration, Platelet Count Decreased, Cytomegalovirus Infection, Blood Pressure Decreased, Immobile, Infestation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
(Rituximab)
Dosage: 758 mg, not reported
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Campath
Dosage: 30 mg, tiw x 18 weeks, subcutaneous
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-07-29
End date: 2011-09-14
Cyclophosphamide
Dosage: 1212 mg
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
Nipent
Dosage: 8 mg
Indication: Chronic Lymphocytic Leukaemia
Start date: 2010-12-27
End date: 2011-05-18
|